Financial poverty indicators still play an important role in policymaking and evaluation. Countries such as the USA and the EU member states use one or several 'official' poverty indicators on which success of poverty reduction policy is regularly monitored. Whereas the US poverty indicator is...

Official poverty methodologies differ from other poverty measurement methods in the sense that the official ones are more often used as a benchmark to develop new policies as well as to evaluate the performance of existing programs. Europe has the tradition and the practice to use relative...

In this study we show that a multidimensional approach to poverty does not have to be used only for summarising poverty in a single index or for comparing deprivation rates between dimensions. We argue and illustrate that such an approach can additionally provide a contribution to a better...

This paper investigates the degree to which monetary poverty and non-monetary deprivation measures identify different groups of vulnerable children; the degree to which children suffer from multiple deprivations across well-being domains; and whether these findings differ systematically across...

Since the start of the transition, the Russian Federation has experienced a number of regulatory and administrative reforms with respect to the provision child benefits. Besides changes in financing from local to federal budget, the introduction of means testing of previously universal child...

This thesis consists of 4 chapters in the field of applied microeconomics. Chapter 1 develops a model of international roaming. International alliances emerge endogenously and serve as a commitment device to soften competition on the retail market. Chapter 2 provides an explanation for why...

This dissertation encompasses three essays on entry and competition in the German generic drug market. The first paper examines the market entry decisions of generic companies and finds that original drug producrs do not create barriers to entry by launching a generic version of the brand drug...